InvestorsObserver
×
News Home

Surface Oncology Inc (SURF) has gained 8.60% in a Week, Should You Hold?

Thursday, August 03, 2023 12:22 PM | InvestorsObserver Analysts

Mentioned in this article

Surface Oncology Inc (SURF) has gained 8.60% in a Week, Should You Hold?

A rating of 90 puts Surface Oncology Inc (SURF) near the top of the Biotechnology industry according to InvestorsObserver. Surface Oncology Inc's score of 90 means it scores higher than 90% of stocks in the industry. Surface Oncology Inc also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 55 out of the 148 industries.

Overall Score - 70
SURF has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on SURF!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Surface Oncology Inc Stock Today?

Surface Oncology Inc (SURF) stock is higher by 14.17% while the S&P 500 is down -0.09% as of 12:17 PM on Thursday, Aug 3. SURF is higher by $0.13 from the previous closing price of $0.89 on volume of 966,520 shares. Over the past year the S&P 500 is up 8.52% while SURF is down -41.95%. SURF lost -$1.49 per share the over the last 12 months. Click Here to get the full Stock Report for Surface Oncology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App